Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study

The selective norepinephrine reuptake inhibitor atomoxetine is potentially among the first-line pharmacotherapy options for ADHD. Therapeutic drug monitoring (TDM) with the quantification and interpretation of atomoxetine serum concentrations is used to determine an individual dose followed by an op...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruppert, Katrin, Geffert, Christoph, Clement, Hans-Willi, Bachmann, Christian, Haberhausen, Michael, Schulz, Eberhard, Fleischhaker, Christian, Biscaldi-Schäfer, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217867/
https://www.ncbi.nlm.nih.gov/pubmed/35391568
http://dx.doi.org/10.1007/s00702-022-02483-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217867/
https://www.ncbi.nlm.nih.gov/pubmed/35391568
http://dx.doi.org/10.1007/s00702-022-02483-8

Ejemplares similares